MOUNTAIN VIEW, Calif., Sept. 21, 2017 -- Blue Jeans Network, Inc. the company that created the cloud video market, today announced that Gartner, Inc. has positioned BlueJeans as a Visionary in its September 2017 Magic Quadrant for Meeting Solutions report. Gartner defines meeting solutions as real-time collaboration tools that support interactions over a network between participants for teamwork, presentations, training, and webinars. The full report is available here.
”BlueJeans prides itself on delivering an easy, one-touch meeting experience, which is one of the top reasons that customers choose our platform,” said Quentin Gallivan, CEO of BlueJeans. “We believe Gartner’s positioning of BlueJeans as a Visionary validates our investments in supporting customer workflows with strategic integrations as well as ongoing interoperability. We will continue to execute on our vision to create meeting experiences that allow users to collaborate more effectively.”
Over the past year, BlueJeans has been rapidly increasing its customer base in size and scope of deployment, with enterprise contracts up nearly 50 percent. Additionally, BlueJeans has doubled the number of both monthly users and meeting minutes run on its platform due to users’ satisfaction with the BlueJeans experience. Customers continue to increase their investments in BlueJeans to take advantage of the platform offerings for meetings, large scale live events, and meeting rooms. To-date, BlueJeans is used in more than 150 countries across six continents.
To view a copy of the report, please visit BlueJeans.
About the Magic Quadrant
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Blue Jeans Network
BlueJeans is the world's leading provider of interoperable video communication, bringing video to you wherever you are. Thousands of global companies use BlueJeans every day for meetings, events, and on social networks across any location or device including mobile, desktop, and room systems. BlueJeans replaces traditional web conferencing technologies for a modern workforce, delivering face-to-face video communication for any organization who wants to bring their employees, leaders, and partners closer together. For more information, visit www.bluejeans.com.
Press Contact:
Megan Maxwell
GMK Communications for BlueJeans
650-810-6658
[email protected]


Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Italy Fines Apple €98.6 Million Over App Store Dominance
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



